The assessment of pathological response to neoadjuvant chemotherapy in muscle- invasive bladder cancer patients with DCE- MRI and DWI: a systematic review and meta-analysis

被引:1
|
作者
Zong, Ruilong [1 ]
Ma, Xijuan [1 ]
Shi, Yibing [1 ]
Geng, Li [2 ]
机构
[1] Xuzhou Cent Hosp, Dept Radiol, Xuzhou 221000, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Radiol, Xuzhou, Peoples R China
来源
BRITISH JOURNAL OF RADIOLOGY | 2023年 / 96卷 / 1150期
关键词
CONTRAST-ENHANCED MRI; URINARY-BLADDER; TUMOR HETEROGENEITY; CELL CARCINOMA; ANGIOGENESIS; DIFFUSIVITY; PREDICTION; CISPLATIN;
D O I
10.1259/bjr.20230239
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: The purpose of this meta-analysis was to determine the value of dynamic contrast-enhanced- MRI (DCE- MRI) and diffusion-weighted imaging (DWI) in evaluating the pathological response of muscle invasive bladder cancer (MIBC) to neoadjuvant chemotherapy (NAC), and further indirectly compare the diagnostic performance of DCE- MRI and DWI. Methods: Literatures associated to DCE- MRI and DWI in the evaluation of pathological response of MIBC to NAC were searched from PubMed, Cochrane Library, web of science, and EMBASE databases. The quality assessment of diagnostic accuracy studies 2 tool was used to assess the quality of studies. Pooled sensitivity (SE), specificity (SP), positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and the area under the receiver operating characteristic curves (AUC) with their 95% confidence intervals (CIs) were calculated to evaluate the diagnostic performance of DCE- MRI and DWI in predicting the pathological response to NAC in patients with MIBC. Results: There were 11 studies involved, 6 of which only underwent DCE-MRI examination, 4 of which only underwent DWI examination, and 1 of which underwent both DCE-MRI and DWI examination. The pooled SE, SP, PLR, NLR, DOR of DCE- MRI were 0.88 (95% CI: 0.78- 0.93), 0.88 (95% CI: 0.67-0.96), 7.4 (95% CI: 2.3-24.2), 0.14 (95% CI: 0.07-0.27), and 53 (95% CI: 10-288), respectively. The pooled SE, SP, PLR, NLR, DOR of DWI were 0.83 (95% CI: 0.75-0.88), 0.88 (95% CI: 0.81-0.93), 7.1 (95% CI: 4.3-11.7), 0.20 (95% CI: 0.14-0.28), and 36 (95% CI:18-73), respectively. The AUCs of SROC curve for DCE- MRI and DWI were 0.93 (95% CI: 0.91-0.95) and 0.92 (95% CI: 0.89-0.94), respectively. There were no significant differences between DWI and DCE- MRI for SE, SP, and AUC. Conclusion: This meta-analysis demonstrated high diagnostic performance of both DCE- MRI and DWI in predicting the pathological response to NAC in MIBC. DWI might be a potential substitute for DCE- MRI, with no significant difference in diagnostic performance between the two. However, caution should be taken when applying our results, as our results were based on indirect comparison. Advances in knowledge: No previous studies have comprehensively analysed the value of DCE- MRI and DWI in evaluating the pathological response to NAC in MIBC. According to the current study, both DCE- MRI and DWI yielded high diagnostic performance, with the AUCs of 0.93 and 0.92, respectively. Indirect comparison no significant difference in the diagnostic performan-ceof DCE- MRI and DWI.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy in invasive bladder cancer:: a systematic review and meta-analysis
    Abol-Enein, H
    Bono, AV
    Boyer, M
    Clarke, NW
    Coppin, CML
    Cortesi, E
    Goebell, PJ
    Groshen, S
    Hall, RR
    Horwich, A
    Malmström, PU
    Martinez-Piñeiro, JA
    Parmar, MKB
    Raghavan, D
    Roberts, JTG
    Sengelov, L
    Sherif, A
    Stewart, LA
    Stockle, M
    Sylvester, R
    Tierney, JF
    Torti, FM
    Vale, CL
    Wallace, DMA
    LANCET, 2003, 361 (9373): : 1927 - 1934
  • [2] Systematic Review and Meta-Analysis of Cisplatin Based Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
    Benkhadra, Raed
    Nayfeh, Tarek
    Patibandla, Sai Krishna
    Peterson, Chelsea
    Prokop, Larry
    Alhalabie, Omar
    Murad, M. Hassan
    Mao, Shifeng S.
    BLADDER CANCER, 2022, 8 (01) : 5 - 17
  • [3] Neoadjuvant Cisplatin-based Chemotherapy in Nonmetastatic Muscle- invasive Bladder Cancer: A Systematic Review and Pooled Meta-analysis to Determine the Preferred Regimen
    Eule, Corbin J.
    Warren, Adam
    Kuna, Elizabeth Molina
    Callihan, Eryn B.
    Kim, Simon P.
    Flaig, Thomas W.
    UROLOGY, 2024, 188 : 118 - 124
  • [4] Neoadjuvant Chemotherapy for Different Stages of Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis
    Liu, Shuai
    Yao, Yu
    Guan, Fengju
    Sun, Lijiang
    Zhang, Guiming
    DISEASE MARKERS, 2022, 2022
  • [5] The utilization status of neoadjuvant chemotherapy in muscle-invasive bladder cancer: a systematic review and meta-analysis
    Liu, Wei
    Tian, Jinhui
    Zhang, Su
    Yang, Enguang
    Shen, Haixiang
    Li, Fudong
    Li, Kailing
    Zhang, Tao
    Wang, Hanzhang
    Svatek, Robert S.
    Rodriguez, Ronald
    Wang, Zhiping
    MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (02): : 144 - 153
  • [6] Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients With MRI-Radiomics: A Systematic Review and Meta-analysis
    Pesapane, Filippo
    Agazzi, Giorgio Maria
    Rotili, Anna
    Ferrari, Federica
    Cardillo, Andrea
    Penco, Silvia
    Dominelli, Valeria
    D'Ecclesiis, Oriana
    Vignati, Silvano
    Raimondi, Sara
    Bozzini, Anna
    Pizzamiglio, Maria
    Petralia, Giuseppe
    Nicosia, Luca
    Cassano, Enrico
    CURRENT PROBLEMS IN CANCER, 2022, 46 (05)
  • [7] Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis
    Yin, Ming
    Joshi, Monika
    Meijer, Richard P.
    Glantz, Michael
    Holder, Sheldon
    Harvey, Harold A.
    Kaag, Matthew
    van de Putte, Elisabeth E. Fransen
    Horenblas, Simon
    Drabick, Joseph J.
    ONCOLOGIST, 2016, 21 (06): : 708 - 715
  • [8] MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis
    Li, Huimin
    Yao, Liang
    Jin, Penghui
    Hu, Lidong
    Li, Xiaofei
    Guo, Tiankang
    Yang, Kehu
    BREAST, 2018, 40 : 106 - 115
  • [9] The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis
    Cheng, Qingqing
    Huang, Jiaxi
    Liang, Jianye
    Ma, Mengjie
    Ye, Kunlin
    Shi, Changzheng
    Luo, Liangping
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [10] Three versus four cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysis
    Wang, Yulong
    Song, Yuxuan
    Qin, Caipeng
    Zhang, Chunlong
    Du, Yiqing
    Xu, Tao
    ANNALS OF MEDICINE, 2023, 55 (02)